Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
08/2003
08/21/2003CA2474195A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/20/2003EP1335905A1 Hetero-anellated ortho-aminophenols and their use as dye components
08/20/2003EP1335900A2 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003CN1118467C 1,3,8-triaza-spiro [4,5] decan-4-on derivatives
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608210 Benzimidazole derivatives, their production and use
08/19/2003US6608097 Materials and methods for the treatment of hypertension and angina
08/19/2003US6608096 Compounds and methods for use thereof in the treatment of cancer or viral infections
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066673A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066622A1 Novel benzimidazole compounds
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003CA2475609A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP0588859B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
08/13/2003CN1436176A 4-alkoxy-cyclohexane-1-amino carboxylic acid esters and method for production thereof
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003US20030149208 Living free radical polymerization initiated by an alkoxyamine initiator or nitroxide
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP0994890B1 Benzimidazole derivatives
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6602832 Oil-soluble additive compositions for lubricating oils
08/05/2003US6602831 Oil-soluble additives for lubricating oils
07/2003
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003US20030144342 alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/31/2003US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis
07/31/2003US20030144281 Substituted benzimidazole compounds
07/30/2003EP1330441A2 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections
07/30/2003EP0592439B1 Aminosulfonyl carbamates
07/30/2003CN1116287C Diphenyl heterocycles as potassium channel modulators
07/29/2003US6600035 6-(substituted methylene) penems and intermediates
07/29/2003CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them
07/24/2003WO2003060956A2 New material for transporting electrons and organic electroluminescent display using the same
07/24/2003WO2003060475A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003WO2003059890A1 Method for the production and purification of 1,7'-dimethyl-2'-propyl-2,5'-bi-1h-benzimidazole
07/24/2003WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
07/24/2003WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003US20030139608 Process for preparing and purifying 1,7' -dimethyl-2' -propyl-2,5'-bi-1H-benzimidazole
07/24/2003US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery
07/24/2003US20030139390 Compounds for the modulation of PPARgamma activity
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/24/2003CA2473236A1 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/23/2003EP0984688B1 Fungicidal mixtures
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431197A Alanine class compound, its preparing method and use
07/23/2003CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol
07/23/2003CN1115336C 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator
07/22/2003US6596877 Reaction with dimethyl carbonate using 4-(dimethylamino)pyridine, 1,4-diazabicyclo(2.2.2)octane, or 1,8-diazabicyclo(5.4.0)undec-7-ene basic catalyst
07/22/2003US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are
07/22/2003US6596751 α-substituted carboxylic acid derivatives
07/17/2003WO2003057675A1 Processes for production of cyclic diamine compounds or salts thereof
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003US20030135056 Imidazole compounds
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030134853 Tetrazolyl- and carbamidosulfonyl-substituted 2-phenyl-1-cycloalkyl -benzimidazoles or -imidazo(4,5b)pyridines that inhibit the RNA-dependent RNA polymerase encoded by Hepatitis C
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326850A1 A process for the preparation of bis-benzazolyl compounds
07/16/2003EP1326845A1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
07/16/2003EP1326844A2 Process for preparation of n-substituted 2-sulfanylimidazoles
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha
07/16/2003CN1429817A Improved production process of 2-butyl-1,3-diaze spiro [4,4] nonane-1-ene-4-ketone
07/16/2003CN1114403C Vitronectin receptor antagonists
07/15/2003US6593476 Process for the preparation of UV filter substances
07/15/2003US6593355 Benzimidazoles with antithrombotic activity
07/15/2003US6593354 Substituted benzoxazole compounds
07/15/2003US6592633 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003WO2003055484A1 Urea derivatives
07/10/2003US20030130331 Crystalline form of telmisartan sodium
07/10/2003US20030130330 Materials and methods for the treatment of hypertension and angina
07/10/2003US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/10/2003US20030130265 Benzimidazole derivatives, a process for their manufacture and use as a medicine
07/10/2003CA2471236A1 Urea derivatives
07/09/2003EP0966465B1 Inhibitors of impdh enzyme
07/09/2003CN1428336A Nitrogen monoxide synthase inhibitor, its preparation method and application
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 154